trial
Longevity Lab
NR supplement fails to slow Parkinson’s disease in major trial
An NR supplement failed to slow Parkinson's disease progression in a major Phase III trial, according to JAMA research.
An NR supplement failed to slow Parkinson's disease progression in a major Phase III trial, according to JAMA research.